187 related articles for article (PubMed ID: 30946340)
1. Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis.
Tao CY; Shang J; Chen T; Yu D; Jiang YM; Liu D; Cheng GY; Xiao J; Zhao ZZ
Medicine (Baltimore); 2019 Apr; 98(14):e15030. PubMed ID: 30946340
[TBL] [Abstract][Full Text] [Related]
2. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Babary H; Liu X; Ayatollahi Y; Chen XP; Doo L; Uppaluru LK; Kwak MK; Kulaga C; Modjinou D; Olech E; Yoo JW
Int J Rheum Dis; 2018 Jan; 21(1):84-92. PubMed ID: 28884965
[TBL] [Abstract][Full Text] [Related]
3. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.
Cairoli E; Rebella M; Danese N; Garra V; Borba EF
Lupus; 2012 Oct; 21(11):1178-82. PubMed ID: 22641182
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review.
Ruiz-Irastorza G; Ramos-Casals M; Brito-Zeron P; Khamashta MA
Ann Rheum Dis; 2010 Jan; 69(1):20-8. PubMed ID: 19103632
[TBL] [Abstract][Full Text] [Related]
6. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies.
Cai T; Zhao J; Yang Y; Jiang Y; Zhang JA
Lupus; 2022 Dec; 31(14):1714-1725. PubMed ID: 36325952
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the disease.
Lang MG; Vinagre CG; Bonfa E; Freitas FR; Pasoto SG; Brito TS; Seguro LP; Maranhão RC; Borba EF
Lupus; 2022 May; 31(6):659-665. PubMed ID: 35332823
[TBL] [Abstract][Full Text] [Related]
9. A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients.
Banach M; Dinca M; Ursoniu S; Serban MC; Howard G; Mikhailidis DP; Nicholls S; Lip GYH; Glasser S; Martin SS; Muntner P; Rysz J; Toth PP; Sahebkar A;
Pharmacol Res; 2016 Sep; 111():343-356. PubMed ID: 27350264
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of effectiveness and safety of glucocorticoid combined with hydroxychloroquine in the treatment of systemic lupus erythematosus rash.
Liang S; Wei Z; Fang H; Guan T
Int J Rheum Dis; 2023 Sep; 26(9):1686-1696. PubMed ID: 37496262
[TBL] [Abstract][Full Text] [Related]
11. Retinal Complications in Patients with Systemic Lupus Erythematosus Treated with Antimalarial Drugs.
Mukwikwi ER; Pineau CA; Vinet E; Clarke AE; Nashi E; Kalache F; Grenier LP; Bernatsky S
J Rheumatol; 2020 Apr; 47(4):553-556. PubMed ID: 31474597
[TBL] [Abstract][Full Text] [Related]
12. Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.
Qin Y; O Santos H; Khani V; Tan SC; Zhi Y
Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1465-1475. PubMed ID: 32675010
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis.
Ji L; Xie W; Fasano S; Zhang Z
Lupus Sci Med; 2022 Jan; 9(1):. PubMed ID: 34996857
[TBL] [Abstract][Full Text] [Related]
14. Effect of coffee consumption on dyslipidemia: A meta-analysis of randomized controlled trials.
Du Y; Lv Y; Zha W; Hong X; Luo Q
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2159-2170. PubMed ID: 33239163
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
Polanski JF; Tanaka EA; Barros H; Chuchene AG; Miguel PTG; Skare TL
Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516
[TBL] [Abstract][Full Text] [Related]
16. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus.
Atta AM; Silva JPCG; Santiago MB; Oliveira IS; Oliveira RC; Sousa Atta MLB
Clin Rheumatol; 2018 Jun; 37(6):1539-1546. PubMed ID: 29516281
[TBL] [Abstract][Full Text] [Related]
18. The effect of tamoxifen on the lipid profile in women: A systematic review and meta-analysis of randomized controlled trials.
Alomar SA; Găman MA; Prabahar K; Arafah OA; Almarshood F; Baradwan S; Aboudi SAS; Abuzaid M; Almubarki AAMA; Alomar O; Al-Badawi IA; Salem H; Abu-Zaid A
Exp Gerontol; 2022 Mar; 159():111680. PubMed ID: 34973347
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis.
Duan J; Ma D; Wen X; Guo Q; Gao J; Zhang G; Xu K; Zhang L
Lupus; 2021 Jun; 30(7):1163-1174. PubMed ID: 33853420
[TBL] [Abstract][Full Text] [Related]
20. The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis.
Munguía-Realpozo P; Mendoza-Pinto C; García-Carrasco M; Berra-Romani R; Sierra-Benito C; Méndez-Martínez S; Cervera R
Autoimmun Rev; 2021 Sep; 20(9):102887. PubMed ID: 34237422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
